Observations from GCP Sponsor Inspections
When it comes to GCP sponsor inspections there are numerous agencies throughout the world that may review your organizational practices.…
Operations
-
-
Is the GAIN Act Stimulating Antibiotic R&D?
In July 2012, the Generating Antibiotic Incentives Now (GAIN) Act was signed into law by the Obama administration as part…
-
The Future of Pfizer’s $5B Brand is in Jeopardy
Lyrica (pregabalin) has been Pfizer’s flagship blockbuster brand for many years due to the fact that it has been approved…
-
The Top 5: November 2018
There were numerous articles in November 2018 that covered a wide range of topical issues. Here are five of the…
-
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
In October, five biosimilar versions of AbbVie’s blockbuster Humira were given the green light to launch in the EU. Humira…
-
The Ongoing Fight Against Diabetes
A question for you: Did you know half of all people living with diabetes are undiagnosed? The International Diabetes Federation…
-
How to Conduct a Diabetes Trial – Lessons Learned
Type 2 diabetes mellitus (T2DM) is increasingly causing alarm among epidemiologists and diabetologists around the world, according to the American…
-
Surveying the Challenges of Preclinical Development
The Preclinical Development Operations Summit launched in 2016 in the East Coast, where a hub of preclinical development companies have…
-
Industry Viewpoints: The Continual Rise of Direct-to-Patient
The rise of direct-to-patient (DtP) shipping seems to know no bounds. The opportunities afforded by DtP means processes can be…
-
Patient-Centric Trials of the Future
The way clinical trials are being conducted needs to change. If the patient’s perspectives, expectations, fears and doubts are not…
